TheraRadar
← Back
Data updated: Mar 29, 2026

PHARMOBEDIENT CNSLTG

DermatologyRespiratoryCardiovascular
Generics

PHARMOBEDIENT CNSLTG is a generic drug manufacturer focused on Dermatology, Respiratory, Cardiovascular.

1983
Since
15
Drugs
-
Trials
243
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

CYCLOSPORINE 2026-01-21
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FLUOXETINE HYDROCHLORIDE 2026-01-15
Manufacturing (CMC)
FUROSEMIDE 2026-01-08
LEVETIRACETAM 2025-12-02
CYCLOSPORINE 2025-11-28
LEVETIRACETAM 2025-11-21
FLUOXETINE HYDROCHLORIDE 2025-09-26
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 40%
2 drugs
Respiratory 20%
1 drugs
Cardiovascular 20%
1 drugs
Immunology 20%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular, Immunology, Respiratory
BAUSCH specialty
Dermatology, Immunology, Cardiovascular
AstraZeneca big-pharma
Respiratory, Cardiovascular, Immunology
COREPHARMA other
Cardiovascular, Respiratory, Immunology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Immunology